About Dr. Balkrishna Padate
Dr. Balkrishna Padate is a leading Haematologist and Bone Marrow Transplant expert in India, bringing over two decades of extensive international experience. Trained extensively in the UK, he holds the prestigious CCST in Haematology and fellowships from the Royal College of Pathologists and Physicians. Padate is a leader in treating complex blood disorders and cancers, including Leukaemia, Lymphoma, and Multiple Myeloma. He is at the forefront of advanced treatments, with profound expertise in Bone Marrow Transplantation (BMT) and pioneering CAR-T therapy in India. Renowned for his meticulous and compassionate approach, he has consistently been named among Mumbai’s best doctors, blending world-class clinical expertise with a deep commitment to patient well-being.
-
- MBBS - Seth GS Medical College and KEM Hospital, Mumbai University (1998)
- MD (Internal Medicine) - LTMMC Sion Hospital, Mumbai University (2003)
-
- FRCP (UK) - Fellow of the Royal College of Physicians, UK
- FRCPATH (UK) - Fellow of the Royal College of Pathologists (Clinical Haematology), UK (2009)
- MRCP (UK) - Member of the Royal College of Physicians, London (2006)
-
- CCST (Certificate of Completion of Specialist Training) in Haematology - The Royal College of Pathologists, London, UK (2011)
-
- Acute & Chronic Leukaemia
- Hodgkin’s & Non-Hodgkin's Lymphoma
- Multiple Myeloma
- Myelodysplastic Syndromes (MDS)
- Myeloproliferative Neoplasms (e.g., Polycythaemia Vera, Myelofibrosis)
- Amyloidosis
-
- Aplastic Anaemia
- Pancytopenia
- Thalassaemia & Sickle Cell Disease
- Immunodeficiency Disorders
- Complex Anaemias, Thrombocytopenia (low platelets)
-
- Bone Marrow Transplantation (BMT) - Autologous, Allogeneic, and Haploidentical
- Stem Cell Transplantation
- CAR-T Cell Therapy
- Advanced Diagnostic and Therapeutic management for all haematological conditions
-
- Current: Director – Haematology, Haemato-Oncology & BMT, H. N. Reliance Foundation Hospital, Mumbai
- Past: Director & Head Consultant, Clinical Haematology & BMT, Nanavati Max Super Speciality Hospital, Mumbai (2021 - 2024)
- Past: Consultant & Head of BMT Programme, P. D. Hinduja Hospital and MRC, Mumbai (2012 - 2021)
- Past: Consultant Haematologist, Maidstone Hospital, NHS, England (2012)
- Past: Senior Registrar (Adult & Paediatric Haematology/BMT), The Royal Free Hospital, University College Hospital London, and St. Mary’s Hospital at Imperial College London.
-
- Honorary Senior Lecturer, University of London (2011 - 2016)
-
- A key figure in establishing and leading high-volume BMT and CAR-T therapy programmes in premier Indian hospitals.
- Brings extensive UK-based training and standards of care to his practice in India.
- Recognised for his expertise in both malignant and complex non-malignant haematology for adults and children.
-
- Awarded Fellowship of the Royal College of Physicians (FRCP), Glasgow (2024)
- Achieved First Rank in MD (Medicine), Mumbai University (2003)
- Received 2nd Prize in Prof. Jaykar Memorial Medicine Examination (2003)
-
- Listed among the Best Doctors in Mumbai by India Today for six consecutive years (2018 - 2024)
-
- Cytogenetic abnormalities in multiple myeloma: Incidence, prognostic significance, and geographic heterogeneity in Indian and western populations, Medical Principles and Practice, (2022)
- Unusual immunophenotype of T-cell large granular lymphocytic leukemia: Report of two cases, Indian Journal of Pathology and Microbiology, (2015)
-
- Dr. Padate has contributed to multiple book chapters and has actively moderated various national and international symposia and panel discussions.
- Dr. Padate has successfully performed hundreds of complex Bone Marrow Transplants for conditions like acute leukaemia and aplastic anaemia. He is one of the few specialists in India leading the charge on CAR-T therapy, offering new hope to patients with relapsed lymphomas and leukaemias.
- "Dr. Padate's expertise in Bone Marrow Transplantation is simply outstanding. He managed my son's high-risk leukaemia with a perfect blend of confidence and compassion. His clarity and approach gave our family the strength to navigate this difficult journey. We are blessed to have found him."
- "After my multiple myeloma relapsed, the future looked bleak. Dr. Padate introduced us to CAR-T therapy. His knowledge and the care his team provided were exceptional. He is not just a doctor; he is a lifesaver who is bringing futuristic treatments to India."
- “Dr Padate is a well experienced BMT doctor in India.”
- Patient-Centred Care: Dr. Padate’s philosophy is rooted in providing humanised care. He dedicates time to ensure patients and their families fully understand the diagnosis and treatment plan, fostering a trusting and supportive environment. His approach is tailored to the individual, prioritising both clinical outcomes and quality of life.
- Technology & Innovation: A firm believer in evidence-based medicine, Dr. Padate combines his vast clinical experience with the latest global advancements. He is a pioneer in adopting cutting-edge cellular therapies like CAR-T and advanced BMT techniques, ensuring his patients have access to the most effective treatments available worldwide.
Treatment/Procedure | Estimated Cost (INR) | Estimated Cost (USD) |
Autologous Bone Marrow Transplant | ₹15,00,000 - ₹20,00,000 | $18,000 - $24,000 |
Allogeneic Bone Marrow Transplant | ₹25,00,000 - ₹40,00,000+ | $30,000 - $48,000+ |
CAR-T Cell Therapy | ₹30,00,000 - ₹50,00,000 | $36,000 - $60,000 |
Chemotherapy for Leukaemia/Lymphoma | ₹5,00,000 - ₹15,00,000 (per cycle/phase) | $6,000 - $18,000 |
- Language Support: Dr. Padate is fluent in English and Hindi. The Cancer Rounds team provides professional interpreters for other languages to ensure seamless communication for international patients.
- Visa & Travel Assistance: Our dedicated team at Cancer Rounds provides comprehensive support, including visa invitation letters, flight arrangements, airport transfers, and booking of accommodation.
- Pre-treatment Virtual Consultations: We facilitate online consultations with Dr. Padate, allowing international patients to have their medical reports reviewed and to receive a preliminary opinion and treatment plan before travelling to India.